Sandra Levy
ARTICLES BY THIS AUTHOR
- 10/2/2019
MedicaSafe partners with Amneal on generic Suboxone monitoring
MedicaSafe will combine Amneal's generic of Suboxone (buprenorphine and naloxone) with its smart medication systems to treat opioid dependence. - 10/2/2019
Diplomat taps David Skomo as CastiaRx COO
Following the retirement of Chris Luthin, David Skomo has been named COO of Diplomat's pharmacy benefit manager CastiaRx. - 10/2/2019
Perrigo relaunches generic Transderm Scop
Transderm Scop and generics had a market value of roughly $147 million for the 12 months ending August 2019. - 10/2/2019
Hy-Vee suspends sale of Zantac and Topcare brand ranitidine products
Hy-Vee has temporarily stopped selling OTC Zantac and Topcare brand ranitidine products, following an FDA alert that these products contain a probable human carcinogen. - 10/2/2019
Teva promotes Eric Drapé to executive vice president of global operations
After more than seven years leading Teva global operations, Carlo de Notaristefani, will retire from Teva. - 10/1/2019
Upsher-Smith launches Tosymra
Tosymra is the third product in Upsher-Smith's migraine portfolio. - 10/1/2019
Lannett enters into distribution agreement for generic Advair Diskus
Under the agreement, Lanett will begin U.S. distribution of Respirent’s generic once the product receives the Food and Drug Administration’s approval. - 10/1/2019
Bartell Drugs collects more than $116,000 through School Tools donation drive
Bartell Drugs in partnership with STAR 101.5 and World Vision are helping more students than ever with the 17th annual School Tools program. - 9/23/2019
Lupin gets FDA nod for generic Unithroid
Levothyroxine sodium tablets had a market value of approximately $2.6 billion, according to IQVIA June 2019 data. - 9/23/2019
Novo Nordisk gets FDA blessing for Rybelsus
Novo Nordisk’s Rybelsus is the first GLP-1 analog treatment available in a pill for adults with Type 2 diabetes.
